Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:14628608rdf:typepubmed:Citationlld:pubmed
pubmed-article:14628608lifeskim:mentionsumls-concept:C0007112lld:lifeskim
pubmed-article:14628608lifeskim:mentionsumls-concept:C0079904lld:lifeskim
pubmed-article:14628608pubmed:issue7lld:pubmed
pubmed-article:14628608pubmed:dateCreated2003-11-21lld:pubmed
pubmed-article:14628608pubmed:abstractTextNuclear factor of kappa B (NF-kappa B) is a multipolar nuclear transcription factor, and adjusts many gene expressions concerned with immunization, apoptosis, inflammation, neoplasia and metastasis. Recently, NF-kappa B has become a kind of hot spot in the studies of neoplasia, infiltration, metastasis and drug resistance. NF-kappa B can serve as an ideal target molecular approach to the promising gene therapy. This article reviews recent advances in studies on the structure and function of NF-kappa B, and the relationship between NF-kappa B and prostatic adenocarcinoma infiltration, metastasis and tactics of gene therapy.lld:pubmed
pubmed-article:14628608pubmed:languagechilld:pubmed
pubmed-article:14628608pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14628608pubmed:citationSubsetIMlld:pubmed
pubmed-article:14628608pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14628608pubmed:statusMEDLINElld:pubmed
pubmed-article:14628608pubmed:monthOctlld:pubmed
pubmed-article:14628608pubmed:issn1009-3591lld:pubmed
pubmed-article:14628608pubmed:authorpubmed-author:GuoHuiHlld:pubmed
pubmed-article:14628608pubmed:authorpubmed-author:ZhouSi-WeiSWlld:pubmed
pubmed-article:14628608pubmed:authorpubmed-author:XiangSong-Tao...lld:pubmed
pubmed-article:14628608pubmed:issnTypePrintlld:pubmed
pubmed-article:14628608pubmed:volume9lld:pubmed
pubmed-article:14628608pubmed:ownerNLMlld:pubmed
pubmed-article:14628608pubmed:authorsCompleteYlld:pubmed
pubmed-article:14628608pubmed:pagination536-8, 542lld:pubmed
pubmed-article:14628608pubmed:meshHeadingpubmed-meshheading:14628608...lld:pubmed
pubmed-article:14628608pubmed:meshHeadingpubmed-meshheading:14628608...lld:pubmed
pubmed-article:14628608pubmed:meshHeadingpubmed-meshheading:14628608...lld:pubmed
pubmed-article:14628608pubmed:meshHeadingpubmed-meshheading:14628608...lld:pubmed
pubmed-article:14628608pubmed:meshHeadingpubmed-meshheading:14628608...lld:pubmed
pubmed-article:14628608pubmed:meshHeadingpubmed-meshheading:14628608...lld:pubmed
pubmed-article:14628608pubmed:meshHeadingpubmed-meshheading:14628608...lld:pubmed
pubmed-article:14628608pubmed:meshHeadingpubmed-meshheading:14628608...lld:pubmed
pubmed-article:14628608pubmed:meshHeadingpubmed-meshheading:14628608...lld:pubmed
pubmed-article:14628608pubmed:meshHeadingpubmed-meshheading:14628608...lld:pubmed
pubmed-article:14628608pubmed:year2003lld:pubmed
pubmed-article:14628608pubmed:articleTitle[NF-kappa B and prostatic adenocarcinoma].lld:pubmed
pubmed-article:14628608pubmed:affiliationDepartment of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China.lld:pubmed
pubmed-article:14628608pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:14628608pubmed:publicationTypeEnglish Abstractlld:pubmed
pubmed-article:14628608pubmed:publicationTypeReviewlld:pubmed